Comparison of Solid Tumor Treatment Response Observed in Clinical Practice With Response Reported in Clinical Trials

IMPORTANCE: In clinical trials supporting the regulatory approval of oncology drugs, solid tumor response is assessed using Response Evaluation Criteria in Solid Tumors (RECIST). Calculation of RECIST-based responses requires sequential, timed imaging data, which presents challenges to the method’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Feinberg, Bruce A., Zettler, Marjorie E., Klink, Andrew J., Lee, Choo H., Gajra, Ajeet, Kish, Jonathan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907955/
https://www.ncbi.nlm.nih.gov/pubmed/33630085
http://dx.doi.org/10.1001/jamanetworkopen.2020.36741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907955/
https://www.ncbi.nlm.nih.gov/pubmed/33630085
http://dx.doi.org/10.1001/jamanetworkopen.2020.36741

Ejemplares similares